Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2024-08-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于拟变更公司董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a proposed change in the company's board of directors, specifically the nomination of a new non-independent director. It includes details about the candidate's background and compliance with relevant laws and regulations. There is no financial data, report, or meeting results presented. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-08-20 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2024 年半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The presence of comprehensive financial metrics and company operational data indicates this is a substantive financial report for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-20 Chinese
关于2024年半年度计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the impairment provision for the first half of 2024. It details the accounting basis, amounts, and impact on financial results but does not contain full financial statements or comprehensive financial analysis typical of an interim or annual report. The document length is short (1312 characters) and it is a specific announcement about asset impairment provisions rather than a full financial report. It is not a certification or a regulatory compliance filing. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2024-08-20 Chinese
关于“重庆医药应收账款2期资产支持专项计划”成功设立的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the successful establishment of a receivables asset-backed special plan by a controlling subsidiary of the company. It includes details about the issuance scale, rating, interest rates, and issuance dates. The document is relatively short (851 characters) and focuses on the issuance results and financing details. This fits the description of a Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes. It is not a full financial report, audit, or regulatory filing, nor is it a report publication announcement. Therefore, the appropriate classification is CAP.
2024-08-13 Chinese
关于董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Zhang Cong, from the board and related committee positions. It includes details about the resignation date, reasons, and confirmation that the board still meets legal requirements. There is no financial data, report, or meeting material presented. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-08-09 Chinese
关于实际控制人拟发生变更事项的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of a change in the actual controlling shareholder of the company. It references previous announcements and regulatory approvals related to the change in control and antitrust review decisions. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a regulatory announcement about ownership and control changes, fitting best under general regulatory filings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-07-18 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.